|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Loss for the Year | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities (a) | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of fixed assets | |||||
| Interest from bank deposit | |||||
| Investment in long-term deposits | |||||
| Acquisition of subsidiary, consolidated for the first time (see Note 5) | |||||
| Loan provided to subsidiary prior to acquisition | |||||
| Proceeds from sale of marketable securities | |||||
| Loan to former subsidiary | |||||
| Cash and cash equivalents of deconsolidated subsidiary (see note 6) | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Loan repayment | |||||
| Issuance of shares and warrants | |||||
| Shareholder loan | |||||
| Net cash provided by financing activities | |||||
| Decrease in cash and cash equivalents | |||||
| Losses from exchange rate differences on cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Depreciation and amortization | |||||
| Change in deferred taxes | |||||
| Revaluation of marketable securities | |||||
| Revaluation of warrants | |||||
| Share-based payment expense | |||||
| Impairment loss on intangible assets | |||||
| Bad debt loss | |||||
| Exchange rate differences | |||||
| Interest income | |||||
| Interest expenses | |||||
| Revaluation of convertible loan | |||||
| Loss from disposal/deconsolidation of subsidiary | |||||
| Net income and expenses not involving operating cash flows | |||||
| Decrease (increase) in prepaid expenses and other current assets | |||||
| Decrease in trade receivables | |||||
| Increase (decrease) in accounts payable | |||||
| Net operating asset and liability | |||||
| Net cash provided by (used in) operating activities | |||||
Loading...